DGX monthly performance report
Explore DGX's monthly returns, drawdown, and seasonality trends — updated every month.
DGX monthly report
—
Key takeaways
- Quest Diagnostics (DGX) closed November 2026 at $259.60, up 3.09% for the month and +38.39% over the trailing 12 months.
- Year-to-date, DGX is +49.60%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +20.38% versus its 200-day moving average ($215.65), a bullish technical signal.
- Over the past three years, DGX has outperformed the S&P 500 by +24.77%, with a relative strength index reading of 114.5.
- Win rate over the trailing 39 months stands at 61.5% — 24 positive months versus 15 negative months.
Quest Diagnostics ended November 2026 at $259.60, posting a monthly return of +3.09%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +3.27%.
The current quarter stands at +11.38% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +20.38% versus the 200-day moving average ($215.65).
Year-to-date, DGX is +49.60% against SPY +10.62%, a gap of +38.98%. The stock is currently −0.90% below its 52-week high, with maximum 3-year drawdown at −12.90%.
| Period | DGX | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.02% | −0.36% | +0.34% |
| 1 Week | +1.55% | +2.59% | −1.04% |
| 1 Month | +3.09% | −0.18% | +3.27% |
| 3 Months | +10.22% | −2.37% | +12.59% |
| 6 Months | +38.13% | +0.83% | +37.30% |
| YTD | +49.60% | +10.62% | +38.98% |
| 12 Months | +38.39% | +12.25% | +26.14% |
| 3 Years | +96.15% | +71.37% | +24.77% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2026 | +13.30% |
| #2 | Aug 2024 | +10.31% |
| #3 | Jul 2026 | +9.94% |
| #4 | Jun 2026 | +8.75% |
| #5 | Aug 2025 | +8.50% |
| Rank | Month | Return |
|---|---|---|
| #1 | Dec 2025 | −8.27% |
| #2 | Oct 2025 | −7.68% |
| #3 | Mar 2026 | −7.52% |
| #4 | Sep 2023 | −7.33% |
| #5 | Dec 2024 | −7.25% |
| Quarter | Return |
|---|---|
| Q3 2025 | +6.10% |
| Q4 2025 | −8.95% |
| Q1 2026 | +12.94% |
| Q2 2026 | +8.15% |
| Q3 2026 | +9.96% |
| Q4 2026 (QTD) | +11.38% |
| Year | Return |
|---|---|
| 2023 | −11.86% |
| 2024 | +9.41% |
| 2025 | +15.03% |
| 2026 | +49.60% |
| Metric | Value |
|---|---|
| 52-Week High | $261.95 (2026-11-12) |
| 52-Week Low | $171.18 (2026-01-05) |
| Current Price | $259.60 |
| 200-Day Moving Average | $215.65 |
| Price vs 200DMA | +20.38% |
| 3-Year Maximum Drawdown | −12.90% (2024-02-05) |
| Current Drawdown from 52W High | −0.90% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 114.5 |
| 3-Year Excess Return vs S&P 500 | +24.77% |
| RS Peak | 115.6 (Nov 2026) |
| RS Trough | 80.9 (Mar 2024) |
| Status | Outperforming Benchmark |
Frequently asked questions
What was DGX's return for this report period?
DGX returned +3.09% in the latest monthly window ending 2026-11-13.
Has DGX outperformed SPY year to date?
YTD DGX: +49.60% vs SPY: +10.62%.
What is DGX's 12-month return?
+38.39% over the trailing 12 months.
Is DGX above or below its 200-day moving average?
Price is +20.38% versus 200DMA ($215.65).
What is the maximum drawdown in the 3-year window?
−12.90% on 2024-02-05.